Injection: 120 mg/1.7 mL prefilled syringe. DIN: 02368153
Comments:
Xgeva is a RANK Ligand inhibitor intended for use in advanced cancer (reduces the risk of developing skeletal-related events in patients with bone metastases from breast cancer, prostate cancer, non-small cell lung cancer and other solid tumors.